Bristol-Myers Squibb to Take Part in Leerink Partners Immuno-Oncology Roundtable Conference
Category:
Thursday, September 22, 2016 9:38 am EDT
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) will take part in Leerink Partners Immuno-Oncology Roundtable Conference on Thursday, September 29, 2016, in New York. Fouad Namouni, senior vice president, Head of Oncology, will answer questions about the company at 3:00 p.m. EDT.
Investors and the general public are invited to listen to a live webcast of the session athttp://investor.bms.com. An archived edition of the session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us onLinkedIn, Twitter, YouTube and Facebook.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.